Outcomes , such as range of motion , recurrence , and clinical success , were frequently defined , however many different definitions were used .
This systematic review summarizes the outcome reporting st and ards in Dupuytren ’s disease treatment research .
Comparison of Treatment Outcome After Collagenase and Needle Fasciotomy for Dupuytren Contracture: A Randomized, Single-Blinded, Clinical Trial With a 1-Year Follow-Up.
PURPOSE This study compared the efficacy of collagenase treatment and needle fasciotomy for contracture of the metacarpophalangeal ( MCP ) joint in Dupuytren disease . METHODS This is a prospect i ve , single-blinded , r and omized study with follow-up 1 week and 1 year after treatment . One hundred and forty patients with an MCP contracture of 20 ° or more in a single finger were enrolled , of whom 69 patients were r and omized to collagenase treatment and 71 patients to needle fasciotomy .  The patients were followed at 1 week and were examined by a physiotherapist after 1 year . Measurements of joint movement and grip strength were recorded as well as patient-perceived outcomes measured by the Unité Rhumatologique des Affections de la Main ( URAM ) question naire and a visual analog scale ( VAS ) for the estimation of procedural pain and subjective treatment efficacy . RESULTS Eighty-eight percent of the patients in the collagenase group and 90 % of the patients in the needle fasciotomy group had a reduction in their MCP contracture to less than 5 ° 1 week after treatment , and the median gains in passive MCP movement were 48 ° and 46 ° , respectively . The median VAS score for procedural pain was 4.9 of 10 in the collagenase group and 2.7 of 10 in the needle fasciotomy group . After 1 year , 90 % of the patients in both groups had full extension of the treated MCP joint . One patient in each group had a recurrence of the contracture . The median improvement in URAM score was 8 units in both groups and the VAS estimation of treatment efficacy by the patients was 8.7 of 10 in both groups . CONCLUSIONS There was no significant difference between the treatment outcomes after collagenase and needle fasciotomy treatment after 1 year . TYPE OF STUDY /LEVEL OF EVIDENCE Therapeutic
Outcomes , such as range of motion , recurrence , and clinical success , were frequently defined , however many different definitions were used .
This systematic review summarizes the outcome reporting st and ards in Dupuytren ’s disease treatment research .